ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ATP5H | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d | Mitochondrial proteins
| | | | | Expressed in all |
ATP5J | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ATP6AP2 | ATPase, H+ transporting, lysosomal accessory protein 2 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATXN3 | Ataxin 3 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
B3GAT1 | Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
B4GALNT1 | Beta-1,4-N-acetyl-galactosaminyl transferase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
B4GALT7 | Xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
BAG1 | BCL2-associated athanogene | Cancer-related genes
| | | | | Expressed in all |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins
| | | | | Tissue enhanced |
BAG5 | BCL2-associated athanogene 5 | | | | | | Expressed in all |
BAIAP2 | BAI1-associated protein 2 | Plasma proteins
| | | | | Expressed in all |
BAIAP2L1 | BAI1-associated protein 2-like 1 | | | | | | Mixed |
BANP | BTG3 associated nuclear protein | | | | | | Expressed in all |
BAX | BCL2-associated X protein | Cancer-related genes Mitochondrial proteins Transporters
| | | | | Expressed in all |
BCAP29 | B-cell receptor-associated protein 29 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
BCAT2 | Branched chain amino-acid transaminase 2, mitochondrial | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Mixed |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
BCL2 | B-cell CLL/lymphoma 2 | Cancer-related genes Disease related genes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
BCL7A | B-cell CLL/lymphoma 7A | Cancer-related genes Disease related genes
| | | | | Expressed in all |
BCL9L | B-cell CLL/lymphoma 9-like | | | | | | Expressed in all |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
BID | BH3 interacting domain death agonist | Mitochondrial proteins
| | | | | Expressed in all |
BIN1 | Bridging integrator 1 | Disease related genes
| | | | | Tissue enriched |
BIN2 | Bridging integrator 2 | Plasma proteins
| | | | | Mixed |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes
| | | | | Mixed |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BMP2K | BMP2 inducible kinase | Enzymes
| | | | | Expressed in all |
BNIP2 | BCL2/adenovirus E1B 19kDa interacting protein 2 | Predicted membrane proteins
| | | | | Expressed in all |
BRAF | V-raf murine sarcoma viral oncogene homolog B | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
BROX | BRO1 domain and CAAX motif containing | | | | | | Expressed in all |
BTF3 | Basic transcription factor 3 | Plasma proteins
| | | | | Expressed in all |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
BTRC | Beta-transducin repeat containing E3 ubiquitin protein ligase | | | | | | Expressed in all |
BUB3 | BUB3 mitotic checkpoint protein | | | | | | Expressed in all |
BUD31 | BUD31 homolog (S. cerevisiae) | | | | | | Expressed in all |
BZW1 | Basic leucine zipper and W2 domains 1 | | | | | | Expressed in all |
C11orf30 | Chromosome 11 open reading frame 30 | Plasma proteins
| | | | | Expressed in all |
C14orf2 | Chromosome 14 open reading frame 2 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
C17orf70 | Chromosome 17 open reading frame 70 | | | | | | Expressed in all |
C1orf116 | Chromosome 1 open reading frame 116 | | | | | | Tissue enhanced |
C1orf198 | Chromosome 1 open reading frame 198 | Predicted secreted proteins
| | | | | Expressed in all |
C1QBP | Complement component 1, q subcomponent binding protein | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | | | | Expressed in all |